Evidence map›Paper›PMID 26060020›Full record

ArticleNature communications2015

Ligand regulation of a constitutively dimeric EGF receptor.

Daniel M Freed, Diego Alvarado, Mark A Lemmon

Abstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Ligand regulation and function of preformed EGFR dimers.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Complex Formation between VEGFR2 and the βCell chemical biology · 2019
    Article
  13. Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitope.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel M FreedDepartment of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine, 322A Clinical Research Building, 415 Curie Boulevard, Philadelphia, Pennsylvania 19104-6059, USA.
Diego AlvaradoDepartment of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine, 322A Clinical Research Building, 415 Curie Boulevard, Philadelphia, Pennsylvania 19104-6059, USA.
Mark A LemmonDepartment of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine, 322A Clinical Research Building, 415 Curie Boulevard, Philadelphia, Pennsylvania 19104-6059, USA.

Funding

Overall (pp. 40-62)P41GM103485 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2012 to 2018
$15.5M
ERBB RECEPTOR HOMO- AND HETERO- DIMERIZATIONR01CA079992 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LEMMON, MARK A · 1999 to 2013
$3.7M
EGFR in a sticky situation: probing structural transitions in dimerized receptorsF32GM109688 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI FREED, DANIEL M · 2014 to 2015
$106k
NCI NIH HHS R01 CA079992NCI NIH HHS R01-CA079992NIGMS NIH HHS F32 GM109688NIGMS NIH HHS F32-GM109688NIGMS NIH HHS GM-103485NIGMS NIH HHS P41 GM103485
6 · The paper itself

Abstract

Ligand-induced receptor dimerization has traditionally been viewed as the key event in transmembrane signalling by epidermal growth factor receptors (EGFRs). Here we show that the Caenorhabditis elegans EGFR orthologue LET-23 is constitutively dimeric, yet responds to its ligand LIN-3 without changing oligomerization state. SAXS and mutational analyses further reveal that the preformed dimer of the LET-23 extracellular region is mediated by its domain II dimerization arm and resembles other EGFR extracellular dimers seen in structural studies. Binding of LIN-3 induces only minor structural rearrangements in the LET-23 dimer to promote signalling. Our results therefore argue that EGFR can be regulated by allosteric changes within an existing receptor dimer--resembling signalling by insulin receptor family members, which share similar extracellular domain compositions but form covalent dimers.

Indexed as

AnimalsCaenorhabditis elegansCell LineDimerizationDrosophila melanogasterErbB ReceptorsLigandsErbB ReceptorsLigands

Identifiers

PMID26060020
PMCPMC4465127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.